Lehman Margot, Jacob Susannah, Delaney Geoff, Papadatos George, Jalaludin Bin, Cail Stacey, McCourt Junee, Wright Suzanne, O'Brien Chris, Barton Michael
Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Radiother Oncol. 2004 Mar;70(3):283-9. doi: 10.1016/j.radonc.2004.01.012.
To determine the maximum time cancer patients were willing to wait for radiotherapy.
Using a trade-off technique (TOT) the maximum time patients were prepared to wait for treatment at the centre closest to home before electing to transfer their care to a centre located (1) at a distance necessitating an extra 30 min travelling each day (MWT 1) or (2) at a distance necessitating staying away from home for the duration of therapy (MWT 2) was determined. A TOT was utilised to determine the loss in treatment effectiveness (LIE 1, LIE 2) patients were willing to accept as a consequence of their MWT 1 and MWT 2 choices.
The median MWT 1 was 4 weeks while the median MWT 2 was 8 weeks. A longer MWT 1 was associated with increasing patient age and a problem with travelling an extra 30 min. Symptomatic patients were less likely to accept a longer MWT 1. The MWT 2 increased as the expected duration of treatment increased but patients in regional areas were less likely to accept a longer MWT 2. The majority of patients indicated that they were unwilling to accept any loss in treatment effectiveness. Patients who had a problem with travelling an extra 30 min daily or who were unable to drive were willing to accept a loss in treatment effectiveness.
This study provides an estimate of the waiting times cancer patients are prepared to accept for radiation therapy and suggests that cancer patients are unlikely to trade-off effectiveness for convenience.
确定癌症患者愿意等待放疗的最长时间。
采用权衡技术(TOT),确定患者在选择将治疗转到离家较近的中心之前,准备在离家最近的中心等待治疗的最长时间,这些中心分别为:(1)距离较远,每天需要额外30分钟行程(MWT 1);(2)距离较远,治疗期间需要离家(MWT 2)。使用TOT确定患者因MWT 1和MWT 2选择而愿意接受的治疗效果损失(LIE 1、LIE 2)。
MWT 1的中位数为4周,而MWT 2的中位数为8周。MWT 1较长与患者年龄增加以及每天额外30分钟行程的问题有关。有症状的患者不太可能接受较长的MWT 1。MWT 2随着预期治疗持续时间的增加而增加,但地区患者不太可能接受较长的MWT 2。大多数患者表示他们不愿意接受治疗效果的任何损失。每天额外行程有问题或无法开车的患者愿意接受治疗效果的损失。
本研究提供了癌症患者准备接受放疗等待时间的估计,并表明癌症患者不太可能为了方便而牺牲治疗效果。